Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Publication of ECSP088334ApublicationCriticalpatent/ECSP088334A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a compuestos de la fórmula (I) (gráfico) y sus sales y solvatos farmacéuticamente aceptables, su síntesis, y su uso como moduladores o inhibidores de la enzima integrasa del virus de la inmunodeficiencia humano ("VIH")The present invention relates to compounds of the formula (I) (graph) and their pharmaceutically acceptable salts and solvates, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus integrase enzyme ("HIV")
ECSP0883342005-10-072008-04-01
INHIBITORS OF THE INTEGRATED HIV ENZYME
ECSP088334A
(en)
SUBSTITUTED DERIVATIVES OF 3- (4-METOXI-PHENYL) -3H-ISOINDOL-1-ILLUMIN TRIFLUOROACETATE, ITS SALTS OR SOLVATOS PHARMACEUTICALLY ACCEPTABLE, PHARMACEUTICAL FORMULATIONS AND APPLICATIONS.
SUBSTITUTED DERIVATIVES OF 2-AMINO-5,6-DIHIDRO PIRIMIDIN-4 (3H) -ONAS AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING AND APPLICATIONS.